Stock Taper
Fortrea Holdings Inc. is a Durham-based CRO providing global clinical development, patient access, and trial technology services for pharma, biotech, and medical device companies across clinical phases I-IV.

Fortrea is a CRO offering comprehensive clinical development solutions, managing all trial phases and post-approval services for the pharmaceutical, biotech, and medical device industries.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Clinical Services Segment | $701.3M | $660.5M ▼ | $636.5M ▼ | $678.2M ▲ |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | North America | $332.7M | $303.1M ▼ | $296.8M ▼ | $319.7M ▲ |
![]() | Europe | $213.2M | $219.5M ▲ | $213.9M ▼ | $219.7M ▲ |
![]() | Other Geographical Areas | $155.4M | $137.9M ▼ | $125.8M ▼ | $138.8M ▲ |
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
XNCR | $26.06 | COMPARE |
VIR | $10.83 | COMPARE |
ANAB | $56.28 | COMPARE |
AVBP | $30.17 | COMPARE |
KURA | $12.66 | COMPARE |
MRVI | $7.68 | COMPARE |
PHAT | $9.18 | COMPARE |
BBOT | $8.74 | COMPARE |